Home/Filings/4/0001209191-22-061746
4//SEC Filing

Ji Henry 4

Accession 0001209191-22-061746

CIK 0000850261other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 8:10 PM ET

Size

7.2 KB

Accession

0001209191-22-061746

Insider Transaction Report

Form 4
Period: 2022-12-15
Ji Henry
DirectorChief Sci. Officer & Secretary10% Owner
Transactions
  • Award

    Common Stock

    2022-12-15+1,500,0006,265,805 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    2,271,693
  • Common Stock

    (indirect: By Spouse)
    40,000
Footnotes (3)
  • [F1]The grant to the Reporting Person of a restricted stock unit award for 1,500,000 shares of the Issuer's common stock (the "RSU Award") was approved by the compensation committee of the board of directors of the Issuer on September 1, 2022 and was granted to the Reporting Person on September 2, 2022. The RSU Award was conditioned upon and subject to the Issuer's stockholders approving an amendment to the Issuer's 2019 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder (the "Plan Amendment"). The Issuer's stockholders approved the Plan Amendment on December 15, 2022.
  • [F2]The reported securities are shares subject to the RSU Award. 1/4th of the shares subject to the RSU Award shall vest on September 2, 2023 and 1/4th of the shares subject to the RSU Award shall vest on each anniversary thereafter.
  • [F3]Shares are held in family trusts of which the Reporting Person is a co-trustee with his spouse.

Issuer

Sorrento Therapeutics, Inc.

CIK 0000850261

Entity typeother

Related Parties

1
  • filerCIK 0001470981

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 8:10 PM ET
Size
7.2 KB